A detailed history of Cedar Mountain Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cedar Mountain Advisors, LLC holds 246 shares of ABBV stock, worth $40,826. This represents 0.01% of its overall portfolio holdings.

Number of Shares
246
Previous 244 0.82%
Holding current value
$40,826
Previous $37,000 18.92%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$159.82 - $182.1 $319 - $364
2 Added 0.82%
246 $44,000
Q4 2023

Jan 16, 2024

BUY
$137.6 - $154.97 $1,788 - $2,014
13 Added 5.63%
244 $37,000
Q3 2023

Oct 23, 2023

BUY
$133.59 - $154.65 $267 - $309
2 Added 0.87%
231 $34,000
Q2 2023

Jul 19, 2023

BUY
$132.51 - $164.9 $2,915 - $3,627
22 Added 10.63%
229 $30,000
Q1 2023

Apr 11, 2023

SELL
$144.61 - $166.54 $11,279 - $12,990
-78 Reduced 27.37%
207 $32,000
Q4 2022

Jan 11, 2023

BUY
$138.31 - $165.87 $276 - $331
2 Added 0.71%
285 $46,000
Q3 2022

Oct 11, 2022

BUY
$134.21 - $153.93 $268 - $307
2 Added 0.71%
283 $38,000
Q2 2022

Jul 14, 2022

BUY
$137.62 - $174.96 $275 - $349
2 Added 0.72%
281 $43,000
Q1 2022

Apr 14, 2022

BUY
$131.98 - $163.75 $263 - $327
2 Added 0.72%
279 $45,000
Q4 2021

Jan 24, 2022

BUY
$107.43 - $135.93 $214 - $271
2 Added 0.73%
277 $38,000
Q3 2021

Oct 15, 2021

BUY
$106.4 - $120.78 $8,724 - $9,903
82 Added 42.49%
275 $29,000
Q2 2021

Jul 15, 2021

BUY
$105.21 - $117.21 $210 - $234
2 Added 1.05%
193 $22,000
Q1 2021

Apr 23, 2021

BUY
$102.3 - $112.62 $306 - $337
3 Added 1.6%
191 $21,000
Q4 2020

Jan 28, 2021

BUY
$80.49 - $108.67 $160 - $217
2 Added 1.08%
188 $20,000
Q3 2020

Oct 21, 2020

BUY
$85.91 - $100.83 $171 - $201
2 Added 1.09%
186 $16,000
Q2 2020

Jul 20, 2020

BUY
$73.37 - $98.18 $146 - $196
2 Added 1.1%
184 $18,000
Q1 2020

Apr 27, 2020

BUY
$64.5 - $97.79 $193 - $293
3 Added 1.68%
182 $14,000
Q4 2019

Jan 30, 2020

BUY
$72.13 - $90.25 $12,911 - $16,154
179 New
179 $16,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cedar Mountain Advisors, LLC Portfolio

Follow Cedar Mountain Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Mountain Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Mountain Advisors, LLC with notifications on news.